Donges, France

Sebastien Daniel Morisseau

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: National Institute of Health and Medical Research, Cytune Pharma, Centre Hospitalier Universitaire De Nantes. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sebastien Daniel Morisseau. Retrieved from https://idiyas.com/inventor/sebastien-daniel-morisseau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0


Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Nantes, FR (2020)
  • Donges, FR (2020 - 2023)

Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Sebastien Daniel Morisseau

Introduction

Sebastien Daniel Morisseau is a notable inventor based in Donges, France. He has made significant contributions to the field of immunocytokines, holding a total of 4 patents. His work focuses on the development of innovative therapeutic solutions that leverage the properties of interleukins.

Latest Patents

Morisseau's latest patents include groundbreaking inventions related to IL-15 and IL-15Rα sushi domain based immunocytokines. These patents describe an immunocytokine that comprises a conjugate and an antibody or a fragment thereof, which is directly or indirectly linked by covalence to the conjugate. The conjugate includes a polypeptide with the amino acid sequence of interleukin 15 or its derivatives, along with a polypeptide that contains the amino acid sequence of the sushi domain of interleukin 15R alpha or its derivatives. These inventions have potential applications in therapeutic treatments.

Career Highlights

Throughout his career, Morisseau has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Cytune Pharma. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Morisseau has collaborated with notable colleagues, including Geraldine Teppaz and Yannick Laurent Joseph Jacques. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.

Conclusion

Sebastien Daniel Morisseau is a prominent inventor whose work in immunocytokines has the potential to impact therapeutic approaches significantly. His contributions and collaborations continue to drive advancements in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…